GGrantIndex
← Leaderboards

Arkadij Elizarov

Trace-Ability, Inc.

Google Scholar ↗PubMed ↗ORCID ↗
$16,153,121
Attributed
$19,840,325
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY2015–25
$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,999,770 · 7
FDA$7,840,555 · 3

By mechanism

R44$11,299,933 · 4
U01$7,672,468 · 2
R43$617,924 · 3
SB1$250,000 · 1

Top collaborators

Most similar at Trace-Ability, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposTracerPositron-Emission TomographyProceduresProductionQuality ControlInnovationOperationRadioactiveAutomationContrast MediaSamplingValidationTechnologyMeasurementSkillsManualsAchievementPositioning AttributeMolecularSiteImageReportingOptics

Grant awards (23)

Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.$1,499,998
R44 · FY2025 · AG · contact PI
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.$1,000,000
R44 · FY2025 · AI · contact PI
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.$1,500,000
R44 · FY2024 · AG · contact PI
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.$1,000,000
R44 · FY2024 · AI · contact PI
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.$93,843
SB1 · FY2024 · CA · contact PI
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.$1,000,000
U01 · FY2023 · FD · contact PI
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.$156,157
SB1 · FY2023 · CA · contact PI
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.$1,252,101
R44 · FY2022 · AG · contact PI
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.$1,000,000
U01 · FY2022 · FD · contact PI
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.$1,256,349
R44 · FY2021 · AG · contact PI
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.$1,000,000
U01 · FY2021 · FD · contact PI
Rapid pre-release sterility test for PET Drugs.$168,087
R43 · FY2021 · FD · contact PI
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.$999,998
U01 · FY2020 · FD · contact PI
Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.$810,570
R44 · FY2020 · MH · contact PI
Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.$689,910
R44 · FY2019 · MH · contact PI
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based cancer imaging PET tracers on a single platform.$299,987
R43 · FY2019 · CA · contact PI
Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG$1,198,721
R44 · FY2018 · CA · contact PI
Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.$232,454
R44 · FY2018 · MH · contact PI
Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.$913,280
U01 · FY2017 · FD · contact PI
Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG$859,830
R44 · FY2017 · CA · contact PI
Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.$959,190
U01 · FY2016 · FD · contact PI
Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.$1,800,000
U01 · FY2015 · FD · contact PI
Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG$149,850
R43 · FY2015 · CA · contact PI